# To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine

> **NCT03654664** · PHASE3 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 119 (actual)

## Conditions studied

- Hepatitis A Vaccine

## Interventions

- **BIOLOGICAL:** Inactivated hepatitis A vaccine
- **BIOLOGICAL:** Havrix Inj

## Key facts

- **NCT ID:** NCT03654664
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-20
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-06-24
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2023-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654664, "To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03654664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*